New rules which aim to crack down on the problem of fake or misleading reviews online came into force back in April 2025, as part of the...

Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...

At the start of the year, our editors (Xisca Borrás, Katie Cambrook and Aida Tohala) presented to you the 12th edition of our Biotech...

Earlier this year, we reported on key considerations that parties involved in the negotiation and drafting of financial milestone...

Earlier this month, Ellen Lambrix and Luca Cericola from Bristows’ Commercial & IP Transactions team attended the Licensing Executives...

In his recent Opinion in Case C-133/24 Tondela and others, Advocate General Emiliou has suggested that a no-poach agreement concluded...

This article was first published in the Bio-science Law Review (Volume 19, Issue 6) by Lawtext Publishing. Cell and Gene Therapies...

In 2024 biotech venture funding in Europe and the US saw a promising increase, reaching a total of $28.1 billion up from $21.2 billion...

The Commission is taking its regular look at the competition rules and guidance applicable to technology licensing agreements, in advance...

The recent social media discussions around the well-known dessert company, Doughnut Time, are a reminder to franchise owners and...

In late 2024, Mr. Justice Adam Johnson delivered his judgment in Zaha Hadid Ltd v Zaha Hadid Foundation [2024] EWHC 3325 (Ch), offering...

As with most industries, sustainability has become a key focus for the fashion and luxury goods industry. In recent years, this has led...